VT
ABBV icon

Vise Technologies’s AbbVie ABBV Stock Holding History

Vise Technologies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.8M Buy
118,244
+50,088
+73% +$10.8M 0.34% 60
2026
Q1 		$15.6M Hold
68,156
– – 0.31% 60
2025
Q4 		$15.6M Buy
68,156
+25,198
+59% +$5.74M 0.31% 60
2025
Q3 		$9.95M Sell
42,958
-3,454
-7% -$703K 0.37% 54
2025
Q2 		$8.62M Buy
+46,412
New +$8.63M 0.36% 50
2024
Q4 		$4.67M Buy
26,275
+5,830
+29% +$1.07M 0.39% 48
2024
Q3 		$4.04M Buy
20,445
+3,123
+18% +$583K 0.51% 41
2024
Q2 		$2.97M Buy
17,322
+1,641
+10% +$272K 0.52% 41
2024
Q1 		$2.86M Sell
15,681
-344
-2% -$59.3K 0.56% 42
2023
Q4 		$2.48M Sell
16,025
-1,269
-7% -$185K 0.53% 45
2023
Q3 		$2.58M Buy
17,294
+3,099
+22% +$455K 0.63% 38
2023
Q2 		$1.91M Sell
14,195
-985
-6% -$144K 0.46% 45
2023
Q1 		$2.42M Buy
15,180
+3,846
+34% +$588K 0.64% 37
2022
Q4 		$1.83M Sell
11,334
-26
-0.2% -$3.99K 0.57% 39
2022
Q3 		$1.52M Buy
11,360
+5,718
+101% +$821K 0.57% 38
2022
Q2 		$864K Buy
5,642
+2,819
+100% +$431K 0.34% 66
2022
Q1 		$458K Buy
+2,823
New +$410K 0.17% 132

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vise Technologies's ABBV Position: Q2 2026 in Review

Vise Technologies increased its AbbVie (ABBV) stake by 73% in Q2 2026, buying an estimated $10.8M and bringing the position to 118,244 shares worth $29.8M. The position accounts for 0.34% of the portfolio, ranked #60.

Vise Technologies first reported a position in ABBV in Q1 2022 and has held it in 17 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Vise Technologies held 118,244 shares of AbbVie worth $29.8M as of Q2 2026.
  • Vise Technologies bought 50,088 AbbVie shares in Q2 2026, an estimated $10.8M.
  • AbbVie made up 0.34% of Vise Technologies's portfolio in Q2 2026, its #60 holding.
  • Vise Technologies first reported a position in AbbVie in Q1 2022 and has held it in 17 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.